Teva Pharmaceutical Industries Limited (BVMF:T1EV34)

BVMF:T1EV34 Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	176,839	197,223	154,662	56,786	53,548	49,226
Market Cap Growth	74.51%	27.52%	172.36%	6.05%	8.78%	-10.37%
Enterprise Value	249,128	279,248	255,321	147,189	160,052	177,988
Last Close Price	78.75	84.48	69.28	25.43	23.88	-
PE Ratio	22.77	25.40	-	-	-	21.19
PS Ratio	1.86	2.08	1.51	0.74	0.68	0.56
PB Ratio	4.06	4.52	4.37	1.44	1.18	0.79
P/FCF Ratio	27.97	31.19	33.39	13.90	9.72	37.44
P/OCF Ratio	19.47	21.71	20.05	8.56	6.37	11.07
EV/Sales Ratio	2.73	2.94	2.50	1.91	2.03	2.01
EV/EBITDA Ratio	9.23	10.23	9.31	6.99	7.63	7.25
EV/EBIT Ratio	11.88	12.83	12.24	9.52	11.37	10.38
EV/FCF Ratio	39.40	44.16	55.12	36.03	29.06	135.36
Debt / Equity Ratio	2.18	2.18	3.18	2.50	2.52	2.10
Debt / EBITDA Ratio	3.39	3.39	3.98	4.53	5.26	5.19
Debt / FCF Ratio	15.01	15.01	24.28	24.08	20.80	99.97
Net Debt / Equity Ratio	1.73	1.73	2.60	2.10	2.19	1.91
Net Debt / EBITDA Ratio	2.76	2.76	3.36	3.93	4.75	4.86
Net Debt / FCF Ratio	11.91	11.91	19.87	20.25	18.11	90.80
Asset Turnover	0.43	0.43	0.40	0.36	0.33	0.32
Inventory Turnover	2.69	2.69	2.41	2.09	2.08	2.02
Quick Ratio	0.54	0.54	0.50	0.54	0.57	0.61
Current Ratio	1.04	1.04	0.98	1.02	1.05	1.14
Return on Equity (ROE)	20.79%	20.79%	-28.30%	-7.36%	-25.19%	4.09%
Return on Assets (ROA)	6.17%	6.17%	5.09%	4.55%	3.63%	3.91%
Return on Invested Capital (ROIC)	18.07%	18.73%	14.74%	12.10%	8.85%	6.18%
Return on Capital Employed (ROCE)	14.50%	14.50%	12.70%	10.20%	8.20%	8.40%
Earnings Yield	4.39%	3.94%	-6.55%	-4.78%	-24.15%	4.72%
FCF Yield	3.58%	3.21%	3.00%	7.20%	10.29%	2.67%
Buyback Yield / Dilution	-2.83%	-2.83%	-1.07%	-0.81%	-0.27%	-1.10%
Total Shareholder Return	-2.83%	-2.83%	-1.07%	-0.81%	-0.27%	-1.10%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.